Lundbeck says cancer drug approved in Canada
COPENHAGEN Aug 28 (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had received approval from Health Canada for its cancer treatment Treanda which is used to treat two common types of cancer including lymphocytic leukaemia.
Lundbeck said the move would substantially strengthen the group's growth outlook, but kept its full-year guidance intact.
It said it expected Treanda would be available to physicians and patients in Canada during September.
(Reporting by Mette Fraende; Editing by Dan Lalor)
- Tweet this
- Share this
- Digg this
- Missing Air Algerie plane from Burkina Faso has crashed - Algerian official
- Alabama man sues, claiming penis amputated instead of circumcised
- Taiwan launches inquiry into plane crash that killed 48
- Wipro sees strong sales growth, eyes Europe deals
- Honda's Mobilio car looks to repeat Indonesia success in India